Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05407701 · ClinicalTrials.gov registry record · NA
Cranberry Ingestion and Cycling Related Immunity and Inflammation
A NA study of Inflammatory Response and Metabolic Disturbance, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT05407701: Completed NA study of Inflammatory Response and Metabolic Disturbance, sponsored by Appalachian State University.
NCT05407701 is a NA study of Inflammatory Response and Metabolic Disturbance that has completed, run by Appalachian State University. The registered enrollment target is 29 participants, below the 176-participant average among 16 other Inflammatory Response trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05407701, a NA study of Inflammatory Response and Metabolic Disturbance, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, crossover clinical trial with 25 male and female cyclists. Study participants will ingest polyphenol-rich cranberry juice or placebo juice for 4 weeks under double-blinded procedures, and then crossover to the opposite supplement. The primary objective of this study is to examine the efficacy of 4-weeks ingestion of cranberry juice in moderating exercise-induced inflammation, immune dysfunction, and muscle damage. Outcome measures will include global proteiomics, oxylipins, and cytokines.
Primary Outcome
The mitogenic response of lymphocytes will be determined in whole blood culture using suboptimal mitogen (Concanavalin A) doses
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Cranberry Juice
Study Locations (1)
North Carolina
- Appalachian State University Human Performance Lab, North Carolina Research Campus - Kannapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2023-01-15 |
| Phase | NA |
What the finished NCT05407701 record still lists
NCT05407701 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 176-participant average among 16 other Inflammatory Response trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Inflammatory Response appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05407701 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05407701 about?
NCT05407701 is a clinical study titled "Cranberry Ingestion and Cycling Related Immunity and Inflammation". This is a randomized, crossover clinical trial with 25 male and female cyclists. Study participants will ingest polyphenol-rich cranberry juice or placebo juice for 4 weeks under double-blinded procedures, and then crossover to the opposite supplement. The primary objective of this study is to exami...
What is the current status of trial NCT05407701?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2022-06-01. Estimated completion is 2023-01-15.
What conditions does trial NCT05407701 study?
This clinical trial studies the following conditions: Inflammatory Response, Metabolic Disturbance, Immune Suppression.
What interventions are being tested in trial NCT05407701?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Cranberry Juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05407701?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05407701 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Response
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05407701's enrollment target sits among peer trials
29 16th of 16 higher than 1 of 16 other Inflammatory Response trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Response trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
RECRUITING · NA
-
Association Between Body Composition and Pain in Spinal Cord Injury
RECRUITING · NA
-
Social Experiences and Demographic Factors in the Regulation of Immune Cells
RECRUITING · NA
-
Daoist Zhanzhuang and Human Flourishing
RECRUITING · NA
-
Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI